Many patients with incurable cancer will receive palliative oncological treatment before their death, and radiotherapy (RT) is an important element of this. The aim of palliative RT is to alleviate symptoms and improve quality of life. An accurate and practical survival prediction model for metastatic cancer patient receiving palliative RT can assist the decision making (ranging from best supportive treatment alone for expected short survival, to dose escalation for potential better disease control). The available survival prediction models (such Survival Prediction Score using Number of Risk Factors by Chow et al and TEACHH model) have been developed in the Western world. We therefore perform a prospective observational study 1) to assess the overall survival of patients evaluated for palliative RT at a tertiary hospital in Hong Kong, and 2) to validate the prognostic score systems in our population.
Study Type
OBSERVATIONAL
Enrollment
450
Radiotherapy for palliating symptoms in stage IV cancer patients
Department of Clinical Oncology, Tuen Mun Hospital, Tuen Mun
Hong Kong, Hong Kong
RECRUITINGOverall Survival
Overall Survival in the studied population
Time frame: 1 year
Overall Survival in Each Indication of Palliative Radiotherapy
Indications of Palliative Radiotherapy: The indication will be as follow: spinal cord compression brain metastases tumor bleeding tumoral mass Cancer pain Superior Vena Cava Syndrome/ Airway compression
Time frame: 3, 6, 9, 12 months
Overall Survival by Survival Prediction Model (NRF)
Overall Survival by Survival Prediction Score using Number of Risk Factors (NRF)
Time frame: 3, 6, 9, 12 months
Overall Survival by Survival Prediction Model (TEACHH)
Overall Survival by Survival Prediction Score using TEACHH Model
Time frame: 3, 6, 9, 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.